QUEST DIAGNOSTICS INC

DGX

Explore Our Financial Data > Companies > QUEST DIAGNOSTICS INC
{{popupValue}}
{{popupSubtitle}}
Documentation
Excel
API
Download

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
DGX
CIK0001022079
SIC8071
SectorServices
Industry CategoryHealthcare
Industry GroupServices – Health

Contact

Address500 PLAZA DRIVE, SECAUCUS, NJ, 07094
Website questdiagnostics.com
Phone9735202700
CEOJames E. Davis
Employees49,000

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$10.85 billion
Pre-Tax Income$1.29 billion
Net Income$1.03 billion
Net Income to Common$969.00 million
EPS$8.52
View All
Balance Sheet
Cash$432.00 million
Assets$16.20 billion
Liabilities$8.82 billion
Common Equity$7.26 billion
Liabilities & Equity$16.20 billion
View All
Cash Flow Statement
Net Income$1.03 billion
Cash From Operating Activities$1.88 billion
Cash From Investing Activities$-942.00 million
Cash From Financing Activities$-1.27 billion
Change in Cash$-332.00 million
View All
Calculations
NOPAT$1.17 billion
EBITDA$2.11 billion
Price to Earnings$20.96
Price to Book$2.80
ROE14.35%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Did Oracle's (ORCL) Debt-Fueled AI Expansion and New Board Member Just Shift Its Investment Narrative?

In recent weeks, Oracle announced it unanimously elected former Quest Diagnostics CEO Stephen Rusckowski to its board, while Orca Security revealed its Cloud Native Application Protection Platform is now available in Oracle Cloud Marketplace for deployment on Oracle Cloud Infrastructure. This period also saw market and analyst focus shift toward Oracle's substantial increase in debt to fund AI data center expansion, prompting debate over its financial risk and reliance on large-scale OpenAI...

Article Link

Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States

MENLO PARK, Calif., December 01, 2025--Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases such as Parkinson’s disease, today announced a strategic collaboration with Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, to make the OctaveⓇ Multiple Sclerosis Disease Activity (MSDA) Test accessible through Quest’s nationwide specimen-collection network.

Article Link

Does Quest Diagnostics Offer Value After 8% Surge and New Partnerships in 2025?

Ever wondered if Quest Diagnostics stock is actually a bargain right now, or just riding the latest market waves? You are in the right place to get some clarity. The stock has made an impressive move, jumping 8.2% over the past month and delivering a strong 25.3% gain year-to-date. There is clear momentum, which may indicate renewed optimism or shifting risk perception. In recent weeks, Quest Diagnostics has been in the spotlight due to fresh partnerships and positive...

Article Link

Why Is DaVita HealthCare (DVA) Up 1.1% Since Last Earnings Report?

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Article Link

Chemed (CHE) Down 5.2% Since Last Earnings Report: Can It Rebound?

Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Article Link